6-OHDA treatment induces BECLIN1 and decreases BCL2 expression and p62 levels, which are inhibited by PERK inhibition (Ning et al., 2019a, b), and this directly cross-links the ER stress and autophagy in 6-OHDA-induced PD pathogenesis. Here, EIF2AK3 is linked to Parkinson disease.